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A report on the Second H3Africa Ethics Consultation Meeting, which was held in Livingstone, Zambia on 11 May 2015. The
meeting demonstrated considerable evolution by African Research Ethics Committees on thinking about broad consent as a
consent option for genomics research and biobanking. The meeting concluded with a call for broader engagement with pol-
icy makers across the continent in order to help these recognise the need for guidance and regulation where these do not
exist and to explore harmonisation where appropriate and possible.
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In May 2015, the H3Africa Consortium hosted the Second
H3Africa Ethics Consultation Meeting, which aimed to con-
tribute to the development of best practice for consent to
genomics and biobanking research in Africa. The meeting,
which targeted members of Research Ethics Committees
(RECs) across Africa participating in H3Africa research,
also explored the relationship between broad consent and
governance of secondary data and sample access. It built
on the ﬁrst H3Africa Ethics Consultation Meeting [1]. The
meeting was attended by close to 80 participants, including
41 members of 31 ethics committees from 15 African coun-
tries. Additional participants were members of the H3Africa
Working Group on Ethics, who facilitated the meeting, and
members of the H3Africa Steering Committee, including
study PIs.
One of the primary topics for discussion related to the
acceptability of broad consent for genomics research and
biobanking. In order to be successfully implemented, it is im-
portant that samples and data collected for genomics re-
search and biobanking are widely available for secondary
use. The requirement for secondary use – meaning that
samples and data can be used for research that was not
part of the original study and that was not anticipated in
the ethics approval process – means that it is difﬁcult to
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seek the speciﬁc consent. The ideal would be to seek the
so-called ‘broad consent’ – consent that allows the broad
re-use of samples and data for future research. Broad con-
sent is not the same as blanket consent, but constitutes con-
sent for samples to be re-used for speciﬁc areas of research,
under a governance framework that regulates access. Some
have called this ‘consent for governance’ [2]. Such consent
for governance is increasingly coming to be seen as an ethi-
cally acceptable consent model for genomics research and
biobanking [3] and there are no compelling reasons for
why broad consent should not be ethically acceptable in
lower- and middle-income countries [4, 5]. However,
there is considerable apprehension about the use of broad
consent for such research, most notably by ethics review
committees [1, 6]. The Second H3Africa Ethics Consultation
Meeting focused on exploring what mechanisms need to be
put in place in order for broad consent to be acceptable for
use in Africa. In particular, we attempted to discuss which
elements the H3Africa governance framework should com-
prise in order to provide appropriate safeguards assuring
ethics committee members that participant interests
would be sufﬁciently protected.
Broad consent
There appeared to have been a remarkable evolution in
approaches to broad consent since the First H3Africa
Ethics Consultation Meeting in 2014, with broad consent
gradually appearing to become the norm for genomic stu-
dies and biobanking in many countries represented at this
meeting. This was most apparent in meeting participants’
greater willingness to explore whether and how broad con-
sent could be adopted as a viable, ethical consent model for
genomics research and biobanking in Africa. This is not to
say that the use of broad consent no longer raises concerns
or questions, or that REC members are no longer consider-
ing the implications of genomics research (and broad con-
sent) on privacy, sovereignty and national heritage, which
remained lively topics of discussion.
What became clear in the course of the discussions was
the need to develop greater conceptual clarity about the dif-
ference between ‘broad’ and ‘blanket’ consent. Emerging in-
ternational consensus would be that blanket consent is
consent without any restrictions on downstream use whilst
broad consent is consent for secondary use with conditions
[3]. These conditions can for instance be speciﬁc areas of
application or provisions for downstream governance, in-
cluding access policies. Where that is desirable, a condition
for secondary use could be that the original REC that ap-
proved sample collection would be involved in secondary
access decisions, or that original committees would be regu-
larly notiﬁed of access decisions. The extent to which orig-
inal ethics committee are or should be involved in reviewing
secondary access and use requests was an important topic
of discussion at the meeting.
During the small group discussions the importance of
education for REC members and policy makers on the ethi-
cal applicability and appropriateness of different consent
models was emphasised. The sentiment was that committee
members (and not just the ones present at the meeting)
should be empowered to make informed decisions about
the acceptability of proposed consent models. This should
include clear guidance about the conditions that should ac-
company broad consent, including appropriate good govern-
ance mechanisms. The important role of community
engagement in supporting the use of broad consent, building
trust between stakeholders as well as conﬁdence in the
governance framework were also discussed.
Deﬁning good governance for genomics and
biobanking
The audience agreed with the Uganda National Council for
Science and Technology that sample and data sharing poli-
cies should take into account the need to respect persons
and communities, be cognisant of and pertinent to the
health of sample donors and their populations, and promote
the fair and equitable sharing of materials in a way that sup-
ports capacity development. Particularly the latter – that
sharing should be fair and of beneﬁt to researchers and
patients in the African context – was considered very im-
portant and received considered attention during the meet-
ing. For African RECs, policy makers and legislators, the key
challenge lies in striking a balance between developing legis-
lation, regulation or guidance that appropriately protects the
interests of African researchers and research participants,
whilst not limiting or restricting opportunities that could
ultimately be beneﬁcial for both. Some important contribu-
tions during the meeting came from participants who shared
perspectives on how restrictive legislation and ethics guid-
ance – developed to prevent exploitation and promote
fairness – could in fact harm these interests by curtailing
opportunities for African scientists to engage in international
collaborations and use novel research methods.
Another important topic of discussion concerned the ex-
tent to which secondary use of samples and data should in-
volve collaboration with scientists from the countries where
the original study took place. This is a regulatory require-
ment in Uganda and other countries and could go some
way in promoting fairness. However, it is not clear how
this is effectively enforced and whether this leads to tokenis-
tic rather than meaningful collaboration, and sustainable ca-
pacity building.
The meeting unearthed a tension between decision-
making by RECs, and policy makers and legislators at
national levels. RECs need to operate within the room for
manoeuvre set by national policy and/or legal frameworks.
Some REC members present at the meeting described
that this sometimes raises tensions, particularly where the
policy or legal framework is very speciﬁc. Others described
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being uneasy about making decisions about genomic re-
search and biobanking where there was a lack of legislation
and regulation.
Participants focused on identifying a number of common
elements of a good governance framework that were
needed to legitimise broad consent, including transparency,
accountability, fairness and consistency in decision-making.
A key question in relation to good governance related to
inclusiveness in the process of policy development and in
decision-making around secondary use, and particularly
about liaising with ethics committees or national ethics
councils in the development of these. There was also con-
siderable focus on the role of Material and, potentially,
Data Transfer Agreements in regulating distant use of sam-
ples and data.
In summary, perspectives on and experiences of broad
consent for genomics research and biobanking in Africa
are evolving, with greater willingness on behalf of African
REC members to consider the conditions under which the
use of broad consent in genomic research and biobanking
in Africa could be ethical. The consensus was that broad
consent should be used in conjunction with a governance
framework regulating secondary sample and data access
and use. Key characteristics of this governance framework
is that it needs to be fair and equitable, promote capacity
building and ultimately empower African researchers to de-
sign, lead and conduct genomics research and biobanking for
the beneﬁt of African patients. The meeting concluded with
a call to develop guidance for what would constitute best
practice in genomics and biobanking research, which could
be used by ethics committees and national ethics councils
to develop their own country-speciﬁc guidance. The
H3Africa Working Group on Ethics is in the process of de-
veloping such guidance in the form of a Framework for Best
Practice for Genomics Research and Biobanking in Africa,
which will be discussed with members of national ethics
councils and governments from over 20 African countries
during the Third H3Africa Ethics Consultation Meeting
that is to be held in Senegal in May 2016.
References
1. de Vries J, et al. Addressing ethical issues in H3Africa
research – the views of research ethics committee members.
HUGO Journal 2015; 9: 1.
2. Sheehan M. Can broad consent be informed consent? Public
Health Ethics 2011; 4: 226–235.
3. Grady C, et al. Broad consent for research with biological
samples: workshop conclusions. AJOB 2015; 15: 34–42.
4. Munung NS, et al. Obtaining informed consent for genomics
research in Africa: analysis of H3Africa consent documents.
Journal of Medical Ethics 2015; 0: 1–6. doi:10.1136/medethics-
2015-102796.
5. Tindana P, De Vries J. Broad consent for genomic research
and biobanking: perspectives from low- and middle-income
countries. Annual Review of Genomics and Human Genetics 2016;
17: 2.1–2.19.
6. Ramsay M, et al. Ethical issues in genomic research on the
African continent: experiences and challenges to ethics review
committees. Human Genomics 2014; 8: 15.
journals.cambridge.org/gheg
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gheg.2016.5
Downloaded from https://www.cambridge.org/core. London School of Hygiene & Tropical Medicine, on 13 Jun 2018 at 12:17:43, subject to the Cambridge Core terms of use, available at
